WFRF:(Bahar A)
Search: WFRF:(Bahar A) > Overview of key mol...
- 10 of 30
- Previous record
- Next record
- To hitlist
Overview of key molecular and pharmacological targets for diabetes and associated diseases
-
- Shahcheraghi, Seyed Hossein (author)
- Shahid Sadoughi Univ Med Sci, Shahid Sadoughi Hosp, Infect Dis Res Ctr, Yazd, Iran; Shahid Sadoughi Univ Med Sci, Sch Med, Dept Med Genet, Yazd, Iran
-
- Aljabali, Alaa A. A. (author)
- Yarmouk Univ, Dept Pharmaceut & Pharmaceut Technol, Irbid, Jordan
-
- Al Zoubi, Mazhar S. (author)
- Yarmouk Univ, Fac Med, Dept Basic Med Sci, Irbid, Jordan
- show more...
- show less...
- (creator_code:org_t)
- Elsevier, 2021
- 2021
- English.
- In: Life Sciences. - : Elsevier. - 0024-3205 .- 1879-0631. ; 278
- Journal article (peer-reviewed)
Abstract
Subject headings
Close
- Diabetes epidemiological quantities are demonstrating one of the most important communities' health worries. The essential diabetic difficulties are including cardiomyopathy, nephropathy, inflammation, and retinopathy. Despite developments in glucose decreasing treatments and drugs, these diabetic complications are still ineffectively reversed or prohibited. Several signaling and molecular pathways are vital targets in the new therapies of diabetes. This review assesses the newest researches about the key molecules and signaling pathways as targets of molecular pharmacology in diabetes and diseases related to it for better treatment based on molecular sciences. The disease is not cured by current pharmacological strategies for type 2 diabetes. While several drug combinations are accessible that can efficiently modulate glycemia and mitigate long-term complications, these agents do not reverse pathogenesis, and in practice, they are not established to modify the patient's specific molecular profiling. Therapeutic companies have benefited from human genetics. Genome exploration, which is agnostic to the information that exists, has revealed tens of loci that impact glycemic modulation. The physiological report has begun to examine subtypes of diseases, illustrate heterogeneity and propose biochemical therapeutic pathways.
Subject headings
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Endokrinologi och diabetes (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Endocrinology and Diabetes (hsv//eng)
Keyword
- Diabetes
- Diabetic complications
- Signaling pathways
- Molecular pharmacology
- Targets
Publication and Content Type
- ref (subject category)
- art (subject category)
Find in a library
- Life Sciences (Search for host publication in LIBRIS)
To the university's database
- 10 of 30
- Previous record
- Next record
- To hitlist
Find more in SwePub
- By the author/editor
- Shahcheraghi, Se ...
- Aljabali, Alaa A ...
- Al Zoubi, Mazhar ...
- Mishra, Vijay
- Charbe, Nitin B.
- Haggag, Yusuf A.
- show more...
- Shrivastava, Gar ...
- Almutary, Abdulm ...
- Alnuqaydan, Abdu ...
- Barh, Debmalya
- Dua, Kamal
- Chellappan, Dine ...
- Gupta, Gaurav
- Lotfi, Marzieh
- Serrano-Aroca, Á ...
- Bahar, Bojlul
- Mishra, Yogendra ...
- Takayama, Kazuo
- Panda, Pritam Ku ...
- Bakshi, Hamid A.
- Tambuwala, Murta ...
- show less...
- About the subject
-
- MEDICAL AND HEALTH SCIENCES
- MEDICAL AND HEAL ...
- and Clinical Medicin ...
- and Endocrinology an ...
- Articles in the publication
- Life Sciences
- By the university
- Uppsala University
Search outside SwePub
- Extend your search to:
- Google Book Search
- Google Scholar
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
- Copyright © LIBRIS - National Library Systems
- LIBRIS.kb.se
